HRS4R
Vull donar
Firma
JUDIT SALAVEDRA-PONT
Posició
Investigador/a Pre-doctoral – R1
Investigadors/es Pre-doctorals – R1

Projectes

Codi oficial: PI23/00517 Data inici: 01/01/2024 Data fi: 31/12/2026 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, ANNA QUIROGA VARELA Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: 2024 PROD 00183 Data inici: 02/12/2024 Data fi: 01/06/2026 Investigador/a principal: JORDI GICH FULLÀ Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA

Publicacions

Salavedra-Pont, J, Coll-Martinez, C, Quiroga-Varela, A, Quintana, E, Buxo, M, Biarnés, C, Robles-Cedeño, R, Alvarez-Bravo, G, Ramio-Torrentà, L, Contreras-Rodriguez, O, Gich, J

From adaptive to maladaptive hippocampal resting-state functional connectivity over the course of multiple sclerosis to understand memory impairment

NEUROIMAGE-CLINICAL, 2025, 48, 103900-103900 dx.doi.org/10.1016/j.nicl.2025.103900
Gich J, Salavedra-Pont J, Coll-Martinez C, Quintana E, Álvarez-Bravo G, Robles-Cedeño R, Buxó M, Contreras-Rodriguez O, Ramió-Torrentà L

The nature of memory impairment in multiple sclerosis: understanding different patterns over the course of the disease

Frontiers in Psychology, 2024, 14, 1269794-1269794 dx.doi.org/10.3389/fpsyg.2023.1269794
Pons, JMH, Coll-Martínez, C, Benavides, AM, Gifreu, A, Pont, JS, Bravo, GCA, Fulla, JG, Torrenta, LRI, Quiroga-Varela, A

Interleukin-8 plasma levels as a potential biomarker for predicting middle-term cognitive outcomes

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 976-977
Coll-Martínez, C, Pont, JS, Pons, JMH, Benavides, AM, Gifreu, A, Bravo, GCA, Quiroga-Varela, A, Ramió-Torrentà, L, Fulla, JG

Cognitive outcomes through MS disease course: 10-year follow-up

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 747-748
Coll-Martínez, C, Pons, JMH, Benavides, AM, Bravo, GCA, Gifreu, A, Pont, JS, Fulla, JG, Torrenta, LRI, Quiroga-Varela, A

Prognostic potential of plasma Interleukin-6 levels as biomarker for long-term cognitive performance

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 981-981
Quiroga-Varela, A, Pons, JMH, Coll-Martínez, C, Benavides, AM, Pont, JS, Gifreu, A, Bravo, GCA, Fulla, JG, Ramió-Torrentà, L

Exploring neurogranin as a potential biomarker for cognitive impairment and disease activity in multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL, 2024, 30, 590-590
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J

Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors

Frontiers in Psychology, 2023, 14, 1163112-1163112 dx.doi.org/10.3389/fpsyg.2023.1163112
Coll-Martínez, C, Quiroga-Varela, A, Pont, JS, Pons, JMH, Benavides, AM, Guimerans, LMV, Casadevall, MP, Gifreu, A, Bravo, GCA, Fulla, JG, Ramió-Torrentà, L

Neurofilament light chain levels in CSF as a potential biomarker for predicting middle-term cognitive outcomes

MULTIPLE SCLEROSIS JOURNAL, 2023, 29, 903-904
Coll-Martinez C, Quintana E, Buxó M, Salavedra-Pont J, Gasull-Vicens L, Quiroga-Varela A, Costa-Frossard L, Villar LM, Fernández-Díaz E, Gracia J, Aladro Y, Méndez-Burgos A, Cerezo M, Ramió-Torrentà L, Gich J

Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68, 104397-104397 dx.doi.org/10.1016/j.msard.2022.104397
Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Brain and Behavior, 2021, 11 dx.doi.org/10.1002/brb3.2405

Formulari de contacte

Coneix l’IDIBGI!

menu